Irish MP calls for key documents on Pandemrix to be handed to lawyers representing children with narcolepsyBMJ 2017; 357 doi: https://doi.org/10.1136/bmj.j1959 (Published 20 April 2017) Cite this as: BMJ 2017;357:j1959
- Clare Dyer
- The BMJ
A member of Dáil Éireann, the Irish parliament, has accused the Irish state body responsible for buying vaccines of choosing GlaxoSmithKline’s Pandemrix for its swine flu programme when it knew it had a higher risk of side effects than other vaccines.
Clare Daly made the allegation in a debate in the Dáil, when she told the taoiseach, Enda Kenny, “The Health Service Executive (HSE) decided to purchase Pandemrix and continued to distribute it even after they knew it was dangerous and untested, and before most of the public in Ireland received it.” The executive knew that there was a seven to eightfold risk of side effects in comparison with a different vaccine, she said.
Around 80 Irish …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial